Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
431-01-013 / 431-01-013 ISMRM Abstract

Changes of T1 signal intensity after brain irradiation in patients with brain metastasis following gadolinium administration

Primary: Contrast Mechanisms - Contrast Agents
Secondary: Neuro - Tumors
431-01-013 · From Microstructure to Metabolism: Next-Generation MRI for Brain Tumors · Tuesday, 12 May, 8:20 AM–9:56 AM · Roof Terrace
431-01-013 · From Microstructure to Metabolism: Next-Generation MRI for Brain Tumors · Tuesday, 12 May, 8:20 AM–9:56 AM · Roof Terrace
Keywords: Magnetic resonance imaging Brain Metastasis Radiation therapy Gadolinium Deposition Gadolinium-based contrast agent
Accepted
Peiying Wei 1, Jianchen Ding2, Zigeng Zhang2, Guangbo Yu2, Aydin Eresen2, Zhijiang Han3, Hongjie Hu3, Zhuoli Zhang2, Zhongxiang Ding4
1Afffliated Hangzhou First People’s Hospital, Westlake University School of Medicine, Hangzhou, China
2University of California, Irvine, United States of America
3Department of Radiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China
4Department of Radiology, Afffliated Hangzhou First People’s Hospital, Westlake University School of Medicine, Hangzhou, China
Presenting Author: Peiying Wei

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Barrios J, Porter E, Capaldi DPI, et al. Multi-institutional atlas of brain metastases informs spatial modeling for precision imaging and personalized therapy. Nat Commun. 2025; 16(1):4536. doi: 10.1038/s41467-025-59584-7. [doi]
2. Boire A, Brastianos PK, Garzia L, et al. Brain metastasis. Nat Rev Cancer. 2020; 20(1):4-11. doi: 10.1038/s41568-019-0220-y. [doi]
3. Gondi V, Bauman G, Bradfield L, et al. Radiation Therapy for Brain Metastases: An ASTRO Clinical Practice Guideline. Pract Radiat Oncol. 2022;12(4):265-282. doi: 10.1016/j.prro.2022.02.003. [doi]
4. Brown PD, Ahluwalia MS, Khan OH, et al. Whole-Brain Radiotherapy for Brain Metastases: Evolution or Revolution? J Clin Oncol. 2018;36(5):483-491. doi: 10.1200/JCO.2017.75.9589. [doi]
5. Yoshida Y, Sejimo Y, Kurachi M, et al. X-ray irradiation induces disruption of the blood-brain barrier with localized changes in claudin-5 and activation of microglia in the mouse brain. Neurochem Int;119:199-206. doi: 10.1016/j.neuint.2018.03.002. [doi]
6. Kiss T, Ungvari A, Gulej R, et al. Whole brain irradiation-induced endothelial dysfunction in the mouse brain. Geroscience. 2024;46(1):531-541. doi: 10.1007/s11357-023-00990-4. [doi]
7. Hart E, Odé Z, Derieppe MPP, et al. Blood-brain barrier permeability following conventional photon radiotherapy - A systematic review and meta-analysis of clinical and preclinical studies. Clin Transl Radiat Oncol. 2022;35:44-55. doi: 10.1016/j.ctro.2022.04.013. [doi]
8. Wang J, Salzillo T, Jiang Y, et al. Stability of MRI contrast agents in high-energy radiation of a 1.5T MR-Linac. Radiother Oncol. 2021;161:55-64. doi: 10.1016/j.radonc.2021.05.023. [doi]
9. Das IJ, McGee KP, Tyagi N, et al. Role and future of MRI in radiation oncology. Br J Radiol. 2019;92(1094):20180505. doi: 10.1259/bjr.20180505. [doi]
10. Wang S, Hesse B, Roman M, et al. Increased Retention of Gadolinium in the Inflamed Brain After Repeated Administration of Gadopentetate Dimeglumine: A Proof-of-Concept Study in Mice Combining ICP-MS and Micro- and Nano-SR-XRF. Invest Radiol. 2019;54(10):617-626. doi: 10.1097/RLI.0000000000000571. [doi]
11. Arena F, Bardini P, Blasi F, et al. Gadolinium presence, MRI hyperintensities, and glucose uptake in the hypoperfused rat brain after repeated administrations of gadodiamide. Neuroradiology. 2019;61(2):163-173. doi: 10.1007/s00234-018-2120-3. [doi]
12. Kromrey ML, Oswald S, Becher D, et al. Intracerebral gadolinium deposition following blood-brain barrier disturbance in two different mouse models. Sci Rep. 2023;13(1):10164. doi: 10.1038/s41598-023-36991-8. [doi]
13. McDonald RJ, McDonald JS, Kallmes DF, et al. Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging. Radiology. 2015;275(3):772-82. doi: 10.1148/radiol.15150025. [doi]
14. Kanda T, Ishii K, Kawaguchi H, et al. High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material. Radiology. 2014;270(3):834-41. doi: 10.1148/radiol.13131669. [doi]
15. Quattrocchi CC, Parillo M, Spani F, et al. Skin Thickening of the Scalp and High Signal Intensity of Dentate Nucleus in Multiple Sclerosis: Association With Linear Versus Macrocyclic Gadolinium-Based Contrast Agents Administration. Invest Radiol. 2023;58(3):223-230. doi: 10.1097/RLI.0000000000000929. [doi]
16. Richter H, Bücker P, Martin LF, et al. Gadolinium Tissue Distribution in a Large-Animal Model after a Single Dose of Gadolinium-based Contrast Agents. Radiology. 2021;301(3):637-642. doi: 10.1148/radiol.2021210553. [doi]
17. Violas X, Rasschaert M, Santus R, et al. Small Brain Lesion Enhancement and Gadolinium Deposition in the Rat Brain: Comparison Between Gadopiclenol and Gadobenate Dimeglumine. Invest Radiol. 2022;57(2):130-139. doi: 10.1097/RLI.0000000000000819. [doi]
18. Zhang Y, Cao Y, Shih GL, et al. Extent of Signal Hyperintensity on Unenhanced T1-weighted Brain MR Images after More than 35 Administrations of Linear Gadolinium-based Contrast Agents. Radiology. 2017;282(2):516-525. doi: 10.1148/radiol.2016152864. [doi]
19. Yao X, Zhang H, Hu J, et al. Effects of Gadolinium Retention in the Brains of Type 2 Diabetic Rats after Repeated Administration of Gadolinium-Based MRI Contrast Agents on Neurobiology and NLRP3 Inflammasome Activation. J Magn Reson Imaging. 2024;60(5):2156-2170. doi: 10.1002/jmri.29313. [doi]
20. Wang C, Tang Y, Tang J, et al. Long-term effects of linear versus macrocyclic GBCAs on gene expression in the central nervous system of mice. Eur Radiol Exp. 2025;9(1):3. doi: 10.1186/s41747-024-00546-x. [doi]
21. Ozturk K, Nascene D. Dentate Nucleus Signal Intensity Changes in Children with Adrenoleukodystrophy in Comparison to Primary Brain Tumor with and without Radiotherapy after Gadobutrol Administration. J Neuroimaging. 2021;31(3):602-608. doi: 10.1111/jon.12844. [doi]
22. Tamrazi B, Nguyen B, Liu CJ, et al. Changes in Signal Intensity of the Dentate Nucleus and Globus Pallidus in Pediatric Patients: Impact of Brain Irradiation and Presence of Primary Brain Tumors Independent of Linear Gadolinium-based Contrast Agent Administration. Radiology. 2018;287(2):452-460. doi: 10.1148/radiol.2017171850. [doi]
23. Kinner S, Schubert TB, Bruce RJ, et al. Deep Brain Nuclei T1 Shortening after Gadobenate Dimeglumine in Children: Influence of Radiation and Chemotherapy. AJNR Am J Neuroradiol. 2018;39(1):24-30. doi: 10.3174/ajnr.A5453. [doi]
24. Lim WH, Choi SH, Yoo RE, et al. Does radiation therapy increase gadolinium accumulation in the brain?: Quantitative analysis of T1 shortening using R1 relaxometry in glioblastoma multiforme patients. PLoS One. 2018;13(2):e0192838. doi: 10.1371/journal.pone.0192838. [doi]
25. Mallio CA, Parillo M, Zobel BB, et al. Effect of Exposure to Gadodiamide and Brain Irradiation on T1 -Weighted Images and ADC Maps of the Dentate Nucleus. J Magn Reson Imaging. 2020;52(5):1525-1530. doi: 10.1002/jmri.27198. [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/431-01-013